JPWO2023163234A5 - - Google Patents
Info
- Publication number
- JPWO2023163234A5 JPWO2023163234A5 JP2024503329A JP2024503329A JPWO2023163234A5 JP WO2023163234 A5 JPWO2023163234 A5 JP WO2023163234A5 JP 2024503329 A JP2024503329 A JP 2024503329A JP 2024503329 A JP2024503329 A JP 2024503329A JP WO2023163234 A5 JPWO2023163234 A5 JP WO2023163234A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- optionally substituted
- groups
- substituted phenylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022030070 | 2022-02-28 | ||
| JP2022067814 | 2022-04-15 | ||
| JP2022106430 | 2022-06-30 | ||
| JP2023001221 | 2023-01-06 | ||
| PCT/JP2023/007434 WO2023163234A1 (ja) | 2022-02-28 | 2023-02-28 | 抗体・薬物コンジュゲート前駆体およびその合成中間体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023163234A1 JPWO2023163234A1 (https=) | 2023-08-31 |
| JPWO2023163234A5 true JPWO2023163234A5 (https=) | 2026-03-06 |
Family
ID=87766353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503329A Pending JPWO2023163234A1 (https=) | 2022-02-28 | 2023-02-28 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250170267A1 (https=) |
| EP (1) | EP4487874A1 (https=) |
| JP (1) | JPWO2023163234A1 (https=) |
| CN (1) | CN119156232A (https=) |
| WO (1) | WO2023163234A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117024438A (zh) * | 2022-07-29 | 2023-11-10 | 杭州爱科瑞思生物医药有限公司 | 依沙替康衍生物及其应用 |
| CN117417347A (zh) * | 2023-09-28 | 2024-01-19 | 杭州爱科瑞思生物医药有限公司 | 卤素取代的依沙替康的酰胺衍生物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2467242A1 (en) | 2001-11-20 | 2003-05-30 | Seattle Genetics, Inc. | Treatment of immunological disorders using anti-cd30 antibodies |
| DK2907824T3 (en) | 2012-10-11 | 2018-07-23 | Daiichi Sankyo Co Ltd | ANTIBODY-drug conjugate |
| EP2910573B1 (en) * | 2012-10-19 | 2020-02-19 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| EP3160513B1 (en) | 2014-06-30 | 2020-02-12 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| CN118652192A (zh) * | 2017-05-24 | 2024-09-17 | 德克萨斯州大学系统董事会 | 用于抗体药物缀合物的接头 |
-
2023
- 2023-02-28 US US18/841,433 patent/US20250170267A1/en active Pending
- 2023-02-28 EP EP23760232.1A patent/EP4487874A1/en active Pending
- 2023-02-28 WO PCT/JP2023/007434 patent/WO2023163234A1/ja not_active Ceased
- 2023-02-28 JP JP2024503329A patent/JPWO2023163234A1/ja active Pending
- 2023-02-28 CN CN202380036429.3A patent/CN119156232A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023163234A5 (https=) | ||
| AU2020202853B2 (en) | PEGylated drug-linkers for improved Ligand-Drug Conjugate pharmacokinetics | |
| KR101988005B1 (ko) | 개선된 연결을 갖는 아마톡신-접합체 | |
| JP6169520B2 (ja) | タンパク質薬剤接合体のための分枝リンカー | |
| CA3044898C (en) | Di-substituted maleic amide linker for antibody-drug conjugating and preparation method and use thereof | |
| KR102466933B1 (ko) | 아마니틴 콘주게이트 | |
| KR102041166B1 (ko) | 개선된 링커를 구비한 아마톡신-접합체 | |
| AU2014210301B2 (en) | Tridentate connexon and use thereof | |
| CA2374964C (en) | Process for producing an injectable medicament preparation | |
| AU2018317230B2 (en) | Tetramaleimide linkers and use thereof | |
| KR102209395B1 (ko) | 새로운 약물-단백질 접합체 | |
| TWI838358B (zh) | 疏水性奧瑞他汀(auristatin)f化合物及其結合物 | |
| WO2019081455A1 (en) | LIGAND-MEDICINAL CONJUGATE COMPRISING A UNIQUE MOLECULAR WEIGHT POLYSARCOSIN | |
| JP2011528360A5 (https=) | ||
| JPWO2023163227A5 (https=) | ||
| AU2006270566A1 (en) | Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes | |
| RU2009121626A (ru) | Соединения агонисты рецептора глюкагоноподобного белка-1 (glp-1r) | |
| HRP20241363T1 (hr) | Konjugat citotoksičnog lijeka i oblik predlijeka navedenog konjugata | |
| US20250082768A1 (en) | Conjugating reagents and conjugates thereof | |
| RU2024128520A (ru) | Конъюгат антитело-лекарственное средство | |
| RU2021110933A (ru) | Линкеры на основе сульфомалеимида и соответствующие конъюгаты | |
| JPWO2020065408A5 (https=) | ||
| JPWO2020132655A5 (https=) | ||
| RU2024139362A (ru) | Конъюгат антитела и нескольких лекарственных средств | |
| RU2021125382A (ru) | Конъюгат антитело-лекарственное средство, нагруженный бинарными токсинами, и его применение |